Tubular tissue construct and a method of printing

A tubular and structural technology, which is applied in the device of human tubular structure, tissue regeneration, processing and manufacturing, etc., can solve the problems that hinder the development of 3D tissue engineering

Pending Publication Date: 2018-04-17
PRESIDENT & FELLOWS OF HARVARD COLLEGE
View PDF8 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The inability to embed vascular networks in tissue constructs h

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tubular tissue construct and a method of printing
  • Tubular tissue construct and a method of printing
  • Tubular tissue construct and a method of printing

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0284] fugitive ink

[0285] Referring to Figure 6A, a high concentration (40wt%) of Pluronic F127A (which was used when the applied shear stress exceeded the shear yield stress (τ y ) (e.g., in printing) exhibits a strong shear-thinning response, and when the applied shear stress is less than τ y The platform shear elastic modulus (G')) which when (for example, after printing) exceeds the shear viscosity modulus (G") was chosen as the fugitive ink for the exemplary system. The elasticity of the fugitive ink was found to be in the range of 22 °C is about 2x 10 4 Pa, as shown in Figure 6B. Below the CMT (approximately 4°C), the ink liquefies and its elasticity decreases by orders of magnitude, facilitating its removal from tissue constructs.

[0286] As noted above, the sacrificial monofilaments formed from escaped ink may include one or more other cells, growth factors, drugs, and the like. For example, endothelial, epithelial, and / or other cells can be dispersed in the ...

Embodiment 2

[0318] Example 2: 3D bioprinting of thick living tissue

[0319] A central issue in the construction of thick living tissues is the design of bio-, sacrificial and elastic inks for multi-material 3D bioprinting.

[0320] method

[0321] Solution preparation :

[0322] Matrix and ink precursor solutions were prepared prior to generation of tissue engineered constructs. A 15 wt / v% gelatin solution (type A, 300 bloom, from pigskin, Sigma) was produced by warming to 70°C in DPBS (1X Dulbelco's phosphate-buffered saline without calcium and magnesium) (unless otherwise indicated), the gelatin powder was then added to the solution while stirring vigorously. The gelatin was completely dissolved by stirring at 70° C. for 12 h (unless otherwise indicated), then the pH was adjusted to 7.5 using 1 M NaOH. The warmed gelatin solution was sterile filtered and stored in aliquots at 4°C for later use (<3 months).

[0323] Prepare fibrinogen solution (50 mg·mL -1 ): Freeze-dried bovi...

Embodiment 3

[0385] Example 3: Bioprinting of coiled 3D renal proximal tubules on a perfusion chip

[0386] Extracellular matrix preparation and rheology

[0387] ECM comprised gelatin and a fibrin network prepared as described in Example 2 above.

[0388] Ink rheology measurements were performed using a controlled stress rheometer (DHR-3, TA Instruments, New Castle, DE) with a 40 mm diameter, 2" cone and plate geometry. Shear storage modulus (C) and loss modulus (G") measured at a frequency of 1 Hz and a vibration stress (γ) of 0.01. Time scanning was performed by rapidly placing a premixed ECM solution containing thrombin on a Peltier plate maintained at 37°C.

[0389] ink preparation

[0390] Two inks are required for 3D bioprinting of perfusable PT models. Both inks were prepared as described in Example 2 above.

[0391] Bioprinting of 3D perfusable proximal tubule constructs

[0392] The 3D PT construct was built using a custom-designed multi-material 3D bioprinter equippe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Elasticityaaaaaaaaaa
Login to view more

Abstract

A 3D printed tubular construct, such as a nephron, with or without embedded vasculature as well as methods of printing tubular tissue constructs are described.

Description

[0001] This patent document claims filing date benefit under 35 U.S.C. § 119(e) to Provisional U.S. Patent Application Serial No. 62 / 157,286, filed May 5, 2015, which is hereby incorporated by reference. [0002] All patents, patent applications and publications, and other references cited herein are hereby incorporated by reference in their entirety. The disclosures of these publications in their entirety are hereby incorporated by reference to more fully describe the state of the art as known to those skilled in the art as of the date of the invention described and claimed herein. [0003] Federally funded research or development [0004] This invention was made with government support under Contract No. CMMI-1548261 awarded by the National Science Foundation EAGER. The government has certain rights in this invention. Background technique [0005] The present disclosure relates generally to tissue engineering and, more particularly, to fabrication of tubular tissue constru...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L27/38A61L27/44A61L27/56C12N5/071
CPCA61L27/56A61L27/3633A61L27/3675A61L27/3808A61L27/3834A61L27/3878A61L27/3891A61L27/50A61L27/54A61L2300/62A61L2300/64A61L2430/32A61F2240/002C12N5/0686B33Y10/00B33Y80/00B29C64/106A61F2/04A61L27/18A61L27/3804A61L2400/08A61L2430/26
Inventor J.A.路易斯K.A.霍曼D.B.克尔斯基R.L.特鲁比M.A.斯凯拉-斯科特
Owner PRESIDENT & FELLOWS OF HARVARD COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products